165 related articles for article (PubMed ID: 38270321)
1. Sufficiently activated mature natural killer cells derived from peripheral blood mononuclear cells substantially enhance antitumor activity.
Liu C; Li Y; Li Y; Hu M; Wang H; Lu S; Li Z; Dilimulati D; Jiao S; Lu S; Zhao W
Immun Inflamm Dis; 2024 Jan; 12(1):e1143. PubMed ID: 38270321
[TBL] [Abstract][Full Text] [Related]
2. IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer.
Felices M; Chu S; Kodal B; Bendzick L; Ryan C; Lenvik AJ; Boylan KLM; Wong HC; Skubitz APN; Miller JS; Geller MA
Gynecol Oncol; 2017 Jun; 145(3):453-461. PubMed ID: 28236454
[TBL] [Abstract][Full Text] [Related]
3. High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor.
Wang F; Zhang G; Xu T; Ma J; Wang J; Liu S; Tang Y; Jin S; Li J; Xing N
J Exp Clin Cancer Res; 2024 Jan; 43(1):24. PubMed ID: 38245792
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo-expanded NK cells from blood and ascites of ovarian cancer patients are cytotoxic against autologous primary ovarian cancer cells.
Nham T; Poznanski SM; Fan IY; Shenouda MM; Chew MV; Lee AJ; Vahedi F; Karimi Y; Butcher M; Lee DA; Hirte H; Ashkar AA
Cancer Immunol Immunother; 2018 Apr; 67(4):575-587. PubMed ID: 29299659
[TBL] [Abstract][Full Text] [Related]
5. Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells.
Pandey V; Oyer JL; Igarashi RY; Gitto SB; Copik AJ; Altomare DA
Oncotarget; 2016 Feb; 7(6):7318-28. PubMed ID: 26802025
[TBL] [Abstract][Full Text] [Related]
6. Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibody.
Lee HR; Son CH; Koh EK; Bae JH; Kang CD; Yang K; Park YS
Sci Rep; 2017 Sep; 7(1):11075. PubMed ID: 28894091
[TBL] [Abstract][Full Text] [Related]
7. High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status.
Veluchamy JP; Heeren AM; Spanholtz J; van Eendenburg JD; Heideman DA; Kenter GG; Verheul HM; van der Vliet HJ; Jordanova ES; de Gruijl TD
Cancer Immunol Immunother; 2017 Jan; 66(1):51-61. PubMed ID: 27783105
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of CD56+ NK and NKT-like lymphocytes from peripheral blood mononuclear cells of patients with ovarian neoplasia.
Alves PCM; De Angelo Andrade LAL; Petta CA; Lorand-Metze I; Derchain SF; Guimarães F
Scand J Immunol; 2011 Sep; 74(3):244-252. PubMed ID: 21595734
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model.
Geller MA; Knorr DA; Hermanson DA; Pribyl L; Bendzick L; McCullar V; Miller JS; Kaufman DS
Cytotherapy; 2013 Oct; 15(10):1297-306. PubMed ID: 23993303
[TBL] [Abstract][Full Text] [Related]
10. Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy.
Liu Y; Wu HW; Sheard MA; Sposto R; Somanchi SS; Cooper LJ; Lee DA; Seeger RC
Clin Cancer Res; 2013 Apr; 19(8):2132-43. PubMed ID: 23378384
[TBL] [Abstract][Full Text] [Related]
11. Endometrial natural killer (NK) cells reveal a tissue-specific receptor repertoire.
Feyaerts D; Kuret T; van Cranenbroek B; van der Zeeuw-Hingrez S; van der Heijden OWH; van der Meer A; Joosten I; van der Molen RG
Hum Reprod; 2018 Mar; 33(3):441-451. PubMed ID: 29447367
[TBL] [Abstract][Full Text] [Related]
12. Non-Coated Rituximab Induces Highly Cytotoxic Natural Killer Cells From Peripheral Blood Mononuclear Cells
Niu C; Chen Y; Li M; Zhu S; Zhou L; Xu D; Li Z; Xu J; Li W; Wang Y; Cui J
Front Immunol; 2021; 12():658562. PubMed ID: 34113342
[TBL] [Abstract][Full Text] [Related]
13. The effect of mifepristone on the peripheral blood natural killer cell's cytotoxicity and expression of CD94/NKG2A and NKG2D during the implantation phase.
Chen XY; Zhuang YL; Li L; Zhang WW; Huang LL
Fertil Steril; 2010 May; 93(8):2615-20. PubMed ID: 19880106
[TBL] [Abstract][Full Text] [Related]
14. Differential microRNA expression between decidual and peripheral blood natural killer cells in early pregnancy.
Carlino C; Rippo MR; Lazzarini R; Monsurrò V; Morrone S; Angelini S; Trotta E; Stabile H; Bastianelli C; Albertini MC; Olivieri F; Procopio A; Santoni A; Gismondi A
Hum Reprod; 2018 Dec; 33(12):2184-2195. PubMed ID: 30388265
[TBL] [Abstract][Full Text] [Related]
15. [Experiment research of natural killer cells amplification in vitro and the killing effect on ovarian cancer cells].
Cheng HY; Ye X; Ma RQ; Chang XH; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):545-550. PubMed ID: 28851172
[No Abstract] [Full Text] [Related]
16. Monocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell lines.
Gottschalk N; Lang S; Kimmig R; Singh M; Brandau S
BMC Cancer; 2012 Oct; 12():451. PubMed ID: 23036052
[TBL] [Abstract][Full Text] [Related]
17. Development of an antibody-ligand fusion protein scFvCD16A
Li Y; Xie S; Chen M; Li H; Wang Y; Fan Y; An K; Wu Y; Xiao W
Microb Cell Fact; 2023 Apr; 22(1):67. PubMed ID: 37041591
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells.
Uppendahl LD; Felices M; Bendzick L; Ryan C; Kodal B; Hinderlie P; Boylan KLM; Skubitz APN; Miller JS; Geller MA
Gynecol Oncol; 2019 Apr; 153(1):149-157. PubMed ID: 30658847
[TBL] [Abstract][Full Text] [Related]
19.
Veluchamy JP; Lopez-Lastra S; Spanholtz J; Bohme F; Kok N; Heideman DA; Verheul HM; Di Santo JP; de Gruijl TD; van der Vliet HJ
Front Immunol; 2017; 8():87. PubMed ID: 28220124
[TBL] [Abstract][Full Text] [Related]
20. Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization.
Pesce S; Greppi M; Tabellini G; Rampinelli F; Parolini S; Olive D; Moretta L; Moretta A; Marcenaro E
J Allergy Clin Immunol; 2017 Jan; 139(1):335-346.e3. PubMed ID: 27372564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
